Home | Welcome to Contract Pharma   
Last Updated Monday, July 28 2014
Print

Topics - Clinical Trial Materials


Refine by Date:
From: To:
Published July 8, 2014
Establishes Phase III agreements for Factor Xa inhibitors Read More »
Published June 27, 2014
Expands support services for biologics development Read More »
Published June 26, 2014
Enables CTM services in more than 44 Asian countries Read More »
Published June 23, 2014
Provides drug product for Phase I trials Read More »
Published June 23, 2014
Aims to provide more efficient Phase I studies Read More »
Published June 10, 2014
Expands services for European markets Read More »
Published May 12, 2014
Will focus on late-stage development for hemophilia products Read More »
Published May 9, 2014
Will provide early stage preclinical to commercial production Read More »
Published May 6, 2014
Cytovance to manufacture SELK2 drug product Read More »
Published May 1, 2014
Filling drug directly into capsules aims to cut time to clinic Read More »
Published April 28, 2014
To use PLX cell therapies in Phase I-III trials Read More »
Published April 25, 2014
Offers delivery of clinical trial drugs to a patient's home or a remote clinic Read More »
Published April 24, 2014
Will support cancer drug development programs Read More »
Published April 7, 2014
To complete studies required for a new manufacturing process Read More »
Published April 3, 2014
Nature and complexity of drug candidates drives increase in use of dedicated supply chain providers Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On